Synthesis and Antiviral and Antitumor Activities of Novel 18β-Glycyrrhetinic Acid Derivatives
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241915012 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bo-Wen Pan und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Guizhou Provincial Basic Research Program, the Innovation Group Project of Guizhou Province, 2023 Natural Science Research Project of Guizhou Provincial Department of Education.
Abstract (Originalsprache)
A series of novel derivatives of 18β-glycyrrhetinic acid (GA) were synthesized by introducing aromatic or heterocyclic structures to extend the side chain, thereby enhancing their interaction with amino acid residues in the active pocket of the target protein. These compounds were structurally characterized using 1H NMR, 13C NMR, and HRMS. The compounds were subsequently evaluated for their inhibitory effects on HIV-1 protease and cell viability in the human cancer cell lines K562 and HeLa and the mouse cancer cell line CT26. Towards HIV-1 protease, compounds 28 and 32, which featured the introduction of heterocyclic moieties at the C3 position of GA, exhibited the highest inhibition, with inhibition rates of 76% and 70.5%, respectively, at 1 mg/mL concentration. Further molecular docking suggests that a 3-substituted polar moiety would be likely to enhance the inhibitory activity against HIV-1 protease. As for the anti-proliferative activities of the GA derivatives, incorporation of a thiazole heterocycle at the C3- position in compound 29 significantly enhanced the effect against K562 cells with an IC50 value of 8.86 ± 0.93 µM. The introduction of electron-withdrawing substituents on the C3-substituted phenyl ring augmented the anti-proliferative activity against Hela and CT26 cells. Compound 13 exhibited the highest inhibitory activity against Hela cells with an IC50 value of 9.89 ± 0.86 µM, whereas compound 7 exerted the strongest inhibition against CT26 cells with an IC50 value of 4.54 ± 0.37 µM. These findings suggest that further modification of GA is a promising path for developing potent novel anti-HIV and anticancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
- College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
ORCID-Profile: Bo-Wen Pan
Förderung
- the Guizhou Provincial Basic Research Program
- the Innovation Group Project of Guizhou Province
- 2023 Natural Science Research Project of Guizhou Provincial Department of Education
- Key Disciplines of Traditional Chinese Medicine and Ethnic Medicine in Guizhou Province during the 14th Five-Year Plan
- the projects of Guizhou province
Zitieren
APA
Pan, B. W., Zheng, L. L., Shi, Y., Dong, Z. C., Feng, T. T., Yang, J., Wei, Y., & Zhou, Y. (2023). Synthesis and Antiviral and Antitumor Activities of Novel 18β-Glycyrrhetinic Acid Derivatives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241915012
Vancouver
Pan BW, Zheng LL, Shi Y, Dong ZC, Feng TT, Yang J, et al. Synthesis and Antiviral and Antitumor Activities of Novel 18β-Glycyrrhetinic Acid Derivatives. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241915012
BibTeX
@article{Pan2023,
author = {Pan, Bo-Wen and Zheng, Liang-Liang and Shi, Yang and Dong, Zhang-Chao and Feng, Ting-Ting and Yang, Jian and Wei, Ying and Zhou, Ying},
title = {Synthesis and Antiviral and Antitumor Activities of Novel 18β-Glycyrrhetinic Acid Derivatives},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241915012}
}
EUVIMED